Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noritaka Ohga

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
International Journal of Oncology|April 30, 2010
Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilizationKunihiko Tsuchiya, Kyoko Hida, Yasuhiro Hida, et al.
The American Journal of Pathology|October 31, 2009
Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumorsTomoshige Akino, Kyoko Hida, Yasuhiro Hida, et al.
The American Journal of Pathology|January 17, 2012
Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumorsNoritaka Ohga, Shuhei Ishikawa, Nako Maishi, et al.
Scientific Reports|June 14, 2016
Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycanNako Maishi, Yusuke Ohba, Kosuke Akiyama, et al.
Cancer Science|March 10, 2022
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery systemNako Maishi, Yu Sakurai, Hiroto Hatakeyama, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
International Journal of Oncology|April 30, 2010
Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilizationKunihiko Tsuchiya, Kyoko Hida, Yasuhiro Hida, et al.
The American Journal of Pathology|October 31, 2009
Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumorsTomoshige Akino, Kyoko Hida, Yasuhiro Hida, et al.
The American Journal of Pathology|January 17, 2012
Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumorsNoritaka Ohga, Shuhei Ishikawa, Nako Maishi, et al.
Scientific Reports|June 14, 2016
Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycanNako Maishi, Yusuke Ohba, Kosuke Akiyama, et al.
Cancer Science|March 10, 2022
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery systemNako Maishi, Yu Sakurai, Hiroto Hatakeyama, et al.
Pageof 7